These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15774500)

  • 1. Glucocorticoid receptor point mutation V571M facilitates coactivator and ligand binding by structural rearrangement and stabilization.
    Carlsson P; Koehler KF; Nilsson L
    Mol Endocrinol; 2005 Aug; 19(8):1960-77. PubMed ID: 15774500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coactivator proteins as determinants of estrogen receptor structure and function: spectroscopic evidence for a novel coactivator-stabilized receptor conformation.
    Tamrazi A; Carlson KE; Rodriguez AL; Katzenellenbogen JA
    Mol Endocrinol; 2005 Jun; 19(6):1516-28. PubMed ID: 15661830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding.
    Rodriguez AL; Tamrazi A; Collins ML; Katzenellenbogen JA
    J Med Chem; 2004 Jan; 47(3):600-11. PubMed ID: 14736241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of the LXXLL motifs of the human glucocorticoid receptor: association with altered ligand affinity.
    Dong DD; Jewell CM; Bienstock RJ; Cidlowski JA
    J Steroid Biochem Mol Biol; 2006 Oct; 101(2-3):106-17. PubMed ID: 16914312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational discovery of a novel interface for a coactivator in the peroxisome proliferator-activated receptor gamma: theoretical implications of impairment in type 2 diabetes mellitus.
    Shiraki T; Kodama TS; Jingami H; Kamiya N
    Proteins; 2005 Feb; 58(2):418-25. PubMed ID: 15558556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.
    Stevens A; Garside H; Berry A; Waters C; White A; Ray D
    Mol Endocrinol; 2003 May; 17(5):845-59. PubMed ID: 12569182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of coregulator-induced conformational perturbations in androgen receptor ligand binding domain.
    Zakharov MN; Pillai BK; Bhasin S; Ulloor J; Istomin AY; Guo C; Godzik A; Kumar R; Jasuja R
    Mol Cell Endocrinol; 2011 Jul; 341(1-2):1-8. PubMed ID: 21605623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolutionary identification of a subtype specific functional site in the ligand binding domain of steroid receptors.
    Raviscioni M; He Q; Salicru EM; Smith CL; Lichtarge O
    Proteins; 2006 Sep; 64(4):1046-57. PubMed ID: 16835908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions.
    Wu J; Li Y; Dietz J; Lala DS
    Mol Endocrinol; 2004 Jan; 18(1):53-62. PubMed ID: 14551261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel point mutation in helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain.
    Nader N; Bachrach BE; Hurt DE; Gajula S; Pittman A; Lescher R; Kino T
    J Clin Endocrinol Metab; 2010 May; 95(5):2281-5. PubMed ID: 20335448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of in vitro peptide binding profiles and in silico ligand-receptor interaction profiles to describe ligand-induced conformations of the retinoid X receptor alpha ligand-binding domain.
    Folkertsma S; van Noort PI; de Heer A; Carati P; Brandt R; Visser A; Vriend G; de Vlieg J
    Mol Endocrinol; 2007 Jan; 21(1):30-48. PubMed ID: 17038419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of LXXLL by ligand binding domain of the Farnesoid X receptor in molecular dynamics simulation.
    Zhang T; Dong XC; Chen MB
    J Chem Inf Model; 2006; 46(6):2623-30. PubMed ID: 17125202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics simulation of the ligand binding domain of farnesoid X receptor. Insights into helix-12 stability and coactivator peptide stabilization in response to agonist binding.
    Costantino G; Entrena-Guadix A; Macchiarulo A; Gioiello A; Pellicciari R
    J Med Chem; 2005 May; 48(9):3251-9. PubMed ID: 15857131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics simulations of human LRH-1: the impact of ligand binding in a constitutively active nuclear receptor.
    Burendahl S; Treuter E; Nilsson L
    Biochemistry; 2008 May; 47(18):5205-15. PubMed ID: 18410128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
    Jeyakumar M; Tanen MR; Bagchi MK
    Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype.
    Charmandari E; Kino T; Souvatzoglou E; Vottero A; Bhattacharyya N; Chrousos GP
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1939-49. PubMed ID: 15070967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helix 12 dynamics and thyroid hormone receptor activity: experimental and molecular dynamics studies of Ile280 mutants.
    Souza PC; Barra GB; Velasco LF; Ribeiro IC; Simeoni LA; Togashi M; Webb P; Neves FA; Skaf MS; Martínez L; Polikarpov I
    J Mol Biol; 2011 Oct; 412(5):882-93. PubMed ID: 21530542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the glucocorticoid receptor DNA-binding domain mimic an allosteric effect of DNA.
    van Tilborg MA; Lefstin JA; Kruiskamp M; Teuben J; Boelens R; Yamamoto KR; Kaptein R
    J Mol Biol; 2000 Aug; 301(4):947-58. PubMed ID: 10966797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homology modelling of the ligand binding domain of mineralocorticoid receptor: close structural kinship with glucocorticoid receptor ligand binding domain and their similar binding mode with DOC (de-oxy corticosterone).
    Dey R; Roychowdhury P
    J Biomol Struct Dyn; 2002 Aug; 20(1):21-9. PubMed ID: 12144349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.
    Charmandari E; Raji A; Kino T; Ichijo T; Tiulpakov A; Zachman K; Chrousos GP
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3696-705. PubMed ID: 15769988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.